Exane Derivatives’s Carlisle Companies CSL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSL
ACM
GIM
FMI
Exane Derivatives's CSL Position: Q2 2022 in Review
Exane Derivatives reduced its Carlisle Companies (CSL) stake by 6.4% in Q2 2022, selling an estimated $14.2K and leaving 831 shares worth $198K. The position accounts for 0.11% of the portfolio, ranked #165.
Exane Derivatives first reported a position in CSL in Q2 2021 and has held it in 5 quarters since. The position peaked at $349K in Q4 2021. 501 funds tracked by Wall St. Rank hold CSL as of Q2 2022.
- Exane Derivatives held 831 shares of Carlisle Companies worth $198K as of Q2 2022.
- Exane Derivatives sold 57 Carlisle Companies shares in Q2 2022, an estimated $14.2K.
- Carlisle Companies made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #165 holding.
- Exane Derivatives first reported a position in Carlisle Companies in Q2 2021 and has held it in 5 quarters since.
- Exane Derivatives's Carlisle Companies position peaked at $349K in Q4 2021.
- 501 funds tracked by Wall St. Rank held Carlisle Companies as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.